Modifying lifestyles might reduce the risk for early age-related macular degeneration as much as 3-fold, lowering the risk for advanced macular degeneration in a person’s lifetime and societal costs. Medscape Medical News
Eye-Pressure-Lowering Drugs May Not Work for Intravitreal Injections
Medicated eye drops used to offset pressure spikes inside the eye have no effect on the pressure caused by intravitreal injections, a new study found. Reuters Health Information
Regeneron And Bayer Report Positive Results For VEGF Trap-Eye In Phase 3 Study In Central Retinal Vein Occlusion (CRVO) And In Phase 2 Study In Diabetic Macular Edema (DME)
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic solution) in the COPERNICUS study, which is led by Regeneron, the first of two Phase 3 studies in patients with mac…
Regeneron And Bayer Report Positive Results For VEGF Trap-Eye In Phase 3 Study In Central Retinal Vein Occlusion (CRVO) And In Phase 2 Study In Diabetic Macular Edema (DME)
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic solution) in the COPERNICUS study, which is led by Regeneron, the first of two Phase 3 studies in patients with mac…
Shopping for Electronic Medical Records
Technology Spotlight
PERGLA Measures Changes After Eye-Pressure Surgery
Pattern electroretinogram optimized for glaucoma screening (PERGLA) appears useful in measuring the reversal of retinal ganglion cell (RGC) dysfunction following surgical treatment of intraocular pressure, according to research published in the Decembe…